DK0552829T3 - CENP-B-peptid - Google Patents

CENP-B-peptid

Info

Publication number
DK0552829T3
DK0552829T3 DK93200062T DK93200062T DK0552829T3 DK 0552829 T3 DK0552829 T3 DK 0552829T3 DK 93200062 T DK93200062 T DK 93200062T DK 93200062 T DK93200062 T DK 93200062T DK 0552829 T3 DK0552829 T3 DK 0552829T3
Authority
DK
Denmark
Prior art keywords
peptide
detection
cenp
anticentromere
autoantibodies
Prior art date
Application number
DK93200062T
Other languages
Danish (da)
English (en)
Inventor
Ronald Verheyen
Venrooy Waltherus Jacobus Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0552829T3 publication Critical patent/DK0552829T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
DK93200062T 1992-01-13 1993-01-12 CENP-B-peptid DK0552829T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200065 1992-01-13

Publications (1)

Publication Number Publication Date
DK0552829T3 true DK0552829T3 (da) 1999-10-25

Family

ID=8210361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93200062T DK0552829T3 (da) 1992-01-13 1993-01-12 CENP-B-peptid

Country Status (12)

Country Link
EP (1) EP0552829B1 (ko)
JP (1) JPH05310790A (ko)
KR (1) KR100296198B1 (ko)
AT (1) ATE179183T1 (ko)
AU (1) AU664063B2 (ko)
CA (1) CA2087143A1 (ko)
DE (1) DE69324509T2 (ko)
DK (1) DK0552829T3 (ko)
ES (1) ES2132171T3 (ko)
FI (1) FI109704B (ko)
GR (1) GR3030727T3 (ko)
ZA (1) ZA93174B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900012B1 (en) 1997-06-03 2005-05-31 The University Of Chicago Plant artificial chromosome compositions and methods
US7119250B2 (en) 1997-06-03 2006-10-10 The University Of Chicago Plant centromere compositions
US7193128B2 (en) 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US7227057B2 (en) 1997-06-03 2007-06-05 Chromatin, Inc. Plant centromere compositions
US7235716B2 (en) 1997-06-03 2007-06-26 Chromatin, Inc. Plant centromere compositions
US6177254B1 (en) * 1998-12-15 2001-01-23 Jerome Bernard Rattner Nucleolus autoantigenic marker for systemic lupus erthyematosus
US7989202B1 (en) 1999-03-18 2011-08-02 The University Of Chicago Plant centromere compositions
CA2557644C (en) 2004-02-23 2016-05-24 Chromatin, Inc. Plants modified with mini-chromosomes
KR100693042B1 (ko) * 2004-11-10 2007-03-12 삼성전자주식회사 무선 전원 공급 장치 및 그 방법
EP2272968A3 (en) 2005-09-08 2011-08-31 Chromatin, Inc. Plants modified with mini-chromosomes
WO2008112972A2 (en) 2007-03-15 2008-09-18 Chromatin, Inc. Centromere sequences and minichromosomes
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
DE102009039705A1 (de) 2009-08-31 2011-04-07 Dr. Fooke Laboratorien Gmbh Peptide des CENP-A und ihre Verwendung
ES2395100B2 (es) * 2011-07-11 2013-09-13 Univ Cadiz Metodo de obtencion de datos utiles para el diagnostico diferencial de la esclerodermia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091303A (en) * 1989-10-27 1992-02-25 The General Hospital Corporation Diagnosis of wegener's granulomatosis

Also Published As

Publication number Publication date
KR100296198B1 (ko) 2001-10-22
KR930016439A (ko) 1993-08-26
GR3030727T3 (en) 1999-11-30
DE69324509T2 (de) 1999-10-07
EP0552829B1 (en) 1999-04-21
FI109704B (fi) 2002-09-30
ES2132171T3 (es) 1999-08-16
FI930106A0 (fi) 1993-01-12
AU664063B2 (en) 1995-11-02
JPH05310790A (ja) 1993-11-22
AU3114993A (en) 1993-07-15
ATE179183T1 (de) 1999-05-15
CA2087143A1 (en) 1993-07-14
FI930106A (fi) 1993-07-14
DE69324509D1 (de) 1999-05-27
EP0552829A1 (en) 1993-07-28
ZA93174B (en) 1993-08-13

Similar Documents

Publication Publication Date Title
DK0552829T3 (da) CENP-B-peptid
DE69332988D1 (de) Reagenzien zum Nachweis und zur Quantifizierung von Thyroxin in flüssigen Proben
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE134880T1 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
DE3270252D1 (en) Radioimmunoassay for fibrinopeptide a
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
EP0656424A3 (de) Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C.
DE69312185D1 (de) Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
DE59108366D1 (de) Verfahren zur Bestimmung eines Analyten
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
FI914673A0 (fi) Peptider, som reagerar immunokemiskt med antikroppar mot hepatitis icke-a, icke-b-virus.
OA09402A (en) A method for the collection of antibodies and the detection of a specific antibody species in a fluid sample and a device for carrying out said method as well as a kit comprising said device.
FI920910A (fi) Peptider som foermaor reagera immunokemiskt med antikroppar mot hepatit ej-a, ej-b -virus
WO1993011158A3 (en) Non-a, non-b peptides
ITMI930477A0 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
EP0096520A3 (en) Antigen detection: rheumatoid arthritis
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
WO1994002507A3 (en) Methods for detecting pre-clinical iddm
DK316089D0 (da) Fremgangsmaade til paavisning af antistoffer eller antigener i et testfluidum samt proevesaet til anvendelse ved fremgangsmaaden
SE7904276L (sv) Renat cancerassocierat protein
DK582288A (da) Analysefremgangsmaade og saet til udfoerelse af fremgangsmaaden
DE58902996D1 (de) Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene.